nach oben

Diabetologia

Erschienen in:

01.11.2012 | Review

Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease

verfasst von: M. A. Atkinson, A. Chervonsky

Erschienen in: Diabetologia | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Despite years of appreciating the potential role of environment to influence the pathogenesis of type 1 diabetes, specific agents or mechanisms serving in such a capacity remain ill defined. This is exceedingly disappointing as the identification of factors capable of modulating the disease, either as triggers or regulators of the autoimmune response underlying type 1 diabetes, would not only provide clues as to why the disorder develops but, in addition, afford opportunities for improved biomarkers of disease activity and the potential to design novel therapeutics capable of disease abatement. Recent improvements in sequencing technologies, combined with increasing appreciation of the role of innate and mucosal immunity in human disease, have stirred strong interest in what is commonly referred to as the ‘gut microbiota’. The gut (or intestinal) microbiota is an exceedingly complex microenvironment that is intimately linked with the immune system, including the regulation of immune responses. After evaluating evidence supporting a role for environment in type 1 diabetes, this review will convey current notions for contributions of the gut microbiota to human health and disease, including information gleaned from studies of humans and animal models for this autoimmune disorder.

Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes; new perspectives on disease pathogenesis and treatment. Lancet 358:221–229PubMedCrossRef

Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300PubMedCrossRef

Trucco M (2009) Gene–environment interaction in type 1 diabetes mellitus. Endocrinol Nutr 56:56–59PubMedCrossRef

Todd JA (2010) Etiology of type 1 diabetes. Immunity 32:457–467PubMedCrossRef

Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247–1257PubMedCrossRef

Knip M, Virtanen SM, Becker D, Dupré J, Krischer JP, Åkerblom HK (2011) Early feeding and risk of type 1 diabetes: experiences from the trial to reduce insulin-dependent diabetes mellitus in the genetically at risk (TRIGR). Am J Clin Nutr 94(Suppl):1814S–1820SPubMedCrossRef

Coppieters KT, Boettler T, von Herrath M (2012) Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med 2:a007682PubMed

Gale EA (2005) Type 1 diabetes in the young: the harvest of sorrow goes on. Diabetologia 48:1435–1438PubMedCrossRef

Soltesz G, Patterson CC, Dahlquist G, EURODIAB Study Group (2007) Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology? Pediatr Diabetes 8:6–14PubMedCrossRef

10.

Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, La Porte R, Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMedCrossRef

11.

Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699–1700PubMedCrossRef

12.

Fourlanos S, Varney MD, Morahan G et al (2008) The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31:1546–1549PubMedCrossRef

13.

Bach JF (2005) Six questions about the hygiene hypothesis. Cell Immunol 233:158–161PubMedCrossRef

14.

Cooke A (2009) Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes? Immunology 126:12–17PubMedCrossRef

15.

von Herrath MG, Fujinami RS, Whitton JL (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1:151–157CrossRef

16.

Rook GA, Adams V, Hunt J et al (2004) Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 25:237–255PubMedCrossRef

17.

Vaarala O, Atkinson MA, Neu J (2008) The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555–2562PubMedCrossRef

18.

Wasserfall C, Nead K, Mathews C, Atkinson MA (2011) The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes. Diabetologia 54:2232–2236PubMedCrossRef

19.

Turnbaugh PJ, Ley RE, Hamady M et al (2007) The human microbiome project. Nature 449:804–810PubMedCrossRef

20.

Boermer BP, Sarvetnick NE (2011) Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann N Y Acad Sci 1243:103–118CrossRef

21.

Ley RE, Lozupone CA, Hamady M et al (2008) Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 6:776–788PubMedCrossRef

22.

Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65PubMedCrossRef

23.

Wu GD, Lewis JD, Hoffmann C et al (2010) Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol 10:206–210PubMedCrossRef

24.

Eckburg PB, Bik EM, Bernstein CN et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638PubMedCrossRef

25.

Gill SR, Pop M, Deboy RT et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359PubMedCrossRef

26.

Walker A, Tarraga AC, Bentley S (2006) Faecal matters. Nat Rev Microbiol 4:572–573PubMedCrossRef

27.

Arumugam M, Raes J, Pelletier E et al (2011) Enterotype of the human gut microbiome. Nature 473:174–180PubMedCrossRef

28.

Sul WJ, Cole JR, Jesus EDC et al (2011) Bacterial community comparisons by taxonomy-supervised analysis independent of sequence alignment and clustering. Proc Natl Acad Sci USA 108:14637–14642PubMedCrossRef

29.

Hamady M, Knight R (2009) Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 19:1141–1152PubMedCrossRef

30.

Momozawa Y, Deffontaine LE, Medrano JF (2011) Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA Gene in Human. PLoS One 6:e16952PubMedCrossRef

31.

Roesch LFW, Casella G, Simell O, Krischer J et al (2009) Influence of fecal sample storage on bacterial community diversity. Open Microbiol J 3:40–46PubMedCrossRef

32.

Pasteur L (1885) Observations relatives à la note précedénte de M. Duclaux. C R Acad Sci (Paris) 100:68

33.

Rahat M, Dimentman C (1982) Cultivation of bacteria-free Hydra viridis: missing budding factor in nonsymbiotic hydra. Science 216:67–68PubMedCrossRef

34.

Kelly D, King T, Aminov R (2001) Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622:58–69

35.

Fagundes CT, Amaral FA, Teixeira AL, Souza DG, Teixeira MM (2012) Adapting to environmental stresses: the role of the microbiota in controlling innate immunity and behavioral responses. Immunol Rev 245:250–264PubMedCrossRef

36.

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229–241PubMedCrossRef

37.

Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28–35PubMedCrossRef

38.

Cerf-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10:735–744PubMedCrossRef

39.

Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al (2008) Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118:205–216PubMedCrossRef

40.

Wu HJ, Ivanov II, Darce J et al (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815–827PubMedCrossRef

41.

Sinkorova Z, Capkova J, Niederlova J, Stepankova R, Sinkora J (2008) Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2^k) male mice. Hum Immunol 69:845–850PubMedCrossRef

42.

Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625PubMedCrossRef

43.

Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498PubMedCrossRef

44.

Gaboriau-Routhiau V, Rakotobe S, Lecuyer E et al (2009) The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677–689PubMedCrossRef

45.

Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D (2011) Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 108:11548–11553PubMedCrossRef

46.

Geuking MB, Cahenzli J, Lawson MA (2011) Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34:794–806PubMedCrossRef

47.

Hoorfar J, Buschard K, Dagnaes-Hansen F (1993) Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice. Br J Nutr 69:597–607PubMedCrossRef

48.

Brugman S, Klatter FA, Visser JT et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105–2108PubMedCrossRef

49.

Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C (2007) Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type-1 diabetes? Diabetologia 49:2105–2108

50.

King C, Sarvetnick N (2011) The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 6:e17049PubMedCrossRef

51.

Satoh J, Shintani S, Oya K, Tanaka S et al (1988) Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 37:1188–1194PubMedCrossRef

52.

Qin HY, Singh B (1997) BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmun 10:271–278PubMedCrossRef

53.

McInerney MF, Pek SB, Thomas DW (1991) Prevention of insulitis and diabetes onset by treatment with complete Freund’s adjuvant in NOD mice. Diabetes 40:715–725PubMedCrossRef

54.

Calcinaro F, Dionisi S, Marinaro M et al (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48:1565–1575PubMedCrossRef

55.

Matsuzaki T, Nagata Y, Kado S et al (1997) Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 105:643–649PubMedCrossRef

56.

Wen L, Ley RE, Volchkov PY et al (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109–1113PubMedCrossRef

57.

Schmid S, Koczwara K, Schwinghammer S et al (2004) Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Clin Immunol 111:108–118PubMedCrossRef

58.

Hansen AK, Ling F, Kaas A et al (2006) Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes Metab Res Rev 22:220–225PubMedCrossRef

59.

Funda DP, Kaas A, Tlaskalova-Hogenova H, Buschard K (2008) Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab Res Rev 24:59–63PubMedCrossRef

60.

Maurano F, Mazzarella G, Luongo D et al (2005) Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 48:931–937PubMedCrossRef

61.

Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP (2010) Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53:741–748PubMedCrossRef

62.

Neu J, Reverte CM, Mackey AD et al (2005) Changes in intestinal morphology and permeability in the BioBreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 40:589–595PubMedCrossRef

63.

Watts T, Berti I, Sapone A et al (2005) Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA 102:2916–2921PubMedCrossRef

64.

Roesch LF, Lorca GL, Casella G et al (2009) Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 3:536–548PubMedCrossRef

65.

Valladares R, Sankar D, Li N et al (2010) Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 6:e10507CrossRef

66.

Lau K, Benitez P, Ardissone A et al (2011) Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 186:3538–3546PubMedCrossRef

67.

Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971–11975PubMedCrossRef

68.

Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R (2009) Bacterial community variation in human body habitats across space and time. Science 326:1694–1697PubMedCrossRef

69.

Moore TA, Hanson CK, Anderson-Berry A (2011) Colonization of the gastrointestinal tract in neonates. ICAN: infant, Child Adolesc Nutr 3:291–295CrossRef

70.

Gronlund MM, Lehtonen OP, Eerola E, Kero P (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28:19–25PubMedCrossRef

71.

Salminen S, Gibson GR, McCartney AL, Isolauri E (2004) Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53:1388–1389PubMedCrossRef

72.

Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51:726–735PubMedCrossRef

73.

Vehik K, Dabelea D (2012) Why are C-section deliveries linked to childhood type 1 diabetes? Diabetes 61:36–37PubMedCrossRef

74.

Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4:478–485PubMedCrossRef

75.

Meddings JB, Jarand J, Urbanski SJ et al (1999) Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 276:G951–G957PubMed

76.

Carratu R, Secondulfo M, de Magistris L et al (1999) Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 28:264–269PubMedCrossRef

77.

Kuitunen M, Saukkonen T, Ilonen J et al (2002) Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity 35:365–368PubMedCrossRef

78.

Bosi E, Molteni L, Radaelli MG et al (2006) Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49:2824–2827PubMedCrossRef

79.

Secondulfo M, Iafusco D, Carratu R et al (2004) Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 36:35–45PubMedCrossRef

80.

Sapone A, de Magistris L, Pietzak M et al (2006) Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55:1443–1449PubMedCrossRef

81.

Tiittanen M, Westerholm-Ormio M, Verkasalo M, Savilahti E, Vaarala O (2008) Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol 152:498–507PubMedCrossRef

82.

Badami E, Sorini C, Coccia M et al (2011) Defective differentiation of regulatory FoxP3⁺ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes 60:2120–2124PubMedCrossRef

83.

Round JL, Mazmanian SK (2010) Inducible Foxp3⁺ regulatory T cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107:12204–12209PubMedCrossRef

84.

Giongo A, Gano KA, Crabb DB et al (2010) Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 5:82–91PubMedCrossRef

85.

Brown CT, Davis-Richardson AG, Giongo A et al (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6:e25792–e25801PubMedCrossRef

86.

Vaarala O (2011) The gut as a regulator of early inflammation in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 18:241–247PubMedCrossRef

87.

Ljungberg M, Korpela R, Ilonen J et al (2006) Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes—the PRODIA study. Ann NY Acad Sci 1079:360–364PubMedCrossRef

88.

Rewers M, Gottlieb P (2009) Immunotherapy for the prevention and treatment of type 1 diabetes. Diabetes Care 32:1769–1782PubMedCrossRef

89.

Martin R, Nauta AJ, Amor KB, Knippels LMJ, Knol J, Garssen J (2010) Early life: gut microbiota and immune development in infancy. Benefic Microbes 1:367–382CrossRef

90.

Scher JU, Abramson SB (2011) The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 7:569–578PubMed

Titel: Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease
verfasst von: M. A. Atkinson
A. Chervonsky
Publikationsdatum: 01.11.2012
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 11/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-012-2672-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2012

Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes

Degradation of islet amyloid polypeptide by neprilysin

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy

The ghrelin O-acyltransferase–ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin